慢性鼻-鼻窦炎患者鼻内镜术后口服鼻渊通窍颗粒效果观察

发布时间：2018-01-28 14:16

本文关键词： 慢性鼻-鼻窦炎鼻渊通窍颗粒鼻内镜手术抗生素鼻腔黏液纤维清除能力生活质量　出处：《山东医药》2017年46期 　论文类型：期刊论文

【摘要】：目的观察慢性鼻-鼻窦炎患者鼻内镜术后口服鼻渊通窍颗粒的临床效果。方法收集慢性鼻-鼻窦炎患者80例,均行鼻内镜术治疗,术后随机分为两组各40例。对照组常规应用抗生素及止血剂治疗,并行鼻内窥镜下鼻腔和鼻窦冲洗;观察组于对照组基础上口服鼻渊通窍颗粒,3次/d。两组均治疗4周,评价两组治疗前后中医症状积分变化,采用视觉模拟评分法(VAS)评价治疗前后疼痛程度,糖精实验观察治疗前后鼻腔黏液纤维清除能力,统计两组临床疗效,并行治疗前后生活质量评分。结果两组治疗前各个指标比较,差异均无统计学意义。两组治疗后中医症状积分、VAS明显低于治疗前(P均0.05),且观察组治疗后中医症状积分、VAS明显低于对照组(P均0.05)。两组治疗后较治疗前鼻腔黏液纤维清除时间缩短、清除率提高、清除速度增加(P均0.05),且观察组较对照组鼻腔黏液纤维清除时间短、清除率高、清除速度快(P均0.05)。观察组、对照组临床治疗有效率分别为95.0%、70.0%,观察组临床治疗有效率高于对照组(P0.05)。两组治疗后各项生活质量评分治疗均较治疗前增加(P均0.05),且观察组各项生活质量评分均高于对照组(P均0.05)。结论慢性鼻-鼻窦炎患者鼻内镜术后口服鼻渊通窍颗粒,可有助于减轻患者临床症状,提高其鼻腔黏液纤维清除能力,从而提高疗效、改善其生活质量。
[Abstract]:Objective to observe the clinical effect of oral Biyuantongqiao granule in patients with chronic rhinosinusitis after nasal endoscopy. Methods 80 patients with chronic rhinosinusitis were treated by nasal endoscopy. The patients in the control group were treated with antibiotics and hemostatic agents, followed by nasal cavity and sinus irrigation under nasal endoscope. The observation group took Biyuan Tongqiao granule 3 times per day on the basis of the control group. The two groups were treated for 4 weeks to evaluate the changes of TCM symptom integral before and after treatment. Visual analogue score (VAS) was used to evaluate the degree of pain before and after treatment, and saccharin experiment was used to observe the ability of nasal mucus fiber clearance before and after treatment, and to calculate the clinical efficacy of the two groups. Results there was no significant difference between the two groups before and after treatment. After treatment, the scores of TCM symptom scores and VAS in the two groups were significantly lower than those before treatment (P 0.05). After treatment, the VAS in the observation group was significantly lower than that in the control group (P < 0.05). After treatment, the clearance time of nasal mucus fibers in the two groups was shorter and the clearance rate was higher than that in the control group. The clearance rate of nasal mucus fibers in the observation group was shorter than that in the control group, the clearance rate was higher and the clearance rate was higher than that in the control group. The effective rate of clinical treatment in the control group was 95.0% and 70.0% respectively. The effective rate of clinical treatment in the observation group was higher than that in the control group (P 0.05). The scores of quality of life in the observation group were all higher than those in the control group (P < 0.05). Conclusion the patients with chronic rhinosinusitis can be treated with nasal endoscopes after nasal endoscopes, which can help to alleviate the clinical symptoms of patients with chronic nasosinusitis. To improve the nasal mucus fiber clearance ability, so as to improve the efficacy and improve the quality of life.
【作者单位】：泰州市人民医院;
【分类号】：R765.9
【正文快照】： 鼻-鼻窦炎是耳鼻喉科常见疾病,该疾病是除患者鼻腔等解剖学结构所致机械性阻塞等,尽鼻腔和鼻窦黏膜的急慢性化脓性炎症,临床以慢可能地保留其有功能的黏膜,但术后全面恢复还性为主。目前,临床药物治疗主要包括抗生素、免需给予必要的治疗和管理[2]。中医在治疗慢性鼻疫调节剂

【相似文献】